| For: | Ratnaparkhi MM, Vyawahare CR, Gandham NR. Hepatitis B virus genotype distribution and mutation patterns: Insights and clinical implications for hepatitis B virus positive patients. World J Exp Med 2025; 15(2): 102395 [PMID: 40546674 DOI: 10.5493/wjem.v15.i2.102395] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i2/102395.htm |
| Number | Citing Articles |
| 1 |
Adane Adugna, Desalegn Abebaw, Tabarak Malik, Mohammed Jemal. Occult hepatitis B virus infection among hepatitis B surface antigen negative vaccinated healthcare workers in East Gojjam zone hospitals. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-025-34788-5
|
| 2 |
Tiffany Fortney, Ambroise D. Ahouidi, Eddie Almaraz, Barbara Harris, Justin Blumenthal, Abbas Hadji, Moustapha Mbow, Cyrille K. Diedhiou, Souadou Ndoye, Noel Magloire Manga, Mary Rodgers, Souleymane Mboup, Gavin Cloherty, Mark Anderson. Detection of Circulating HBV QSA3/E Recombinants and HDV Genotype GT5 amongst blood donors in Senegal. International Journal of Infectious Diseases 2026; : 108541 doi: 10.1016/j.ijid.2026.108541
|
| 3 |
Manisha M Ratnaparkhi, Chanda R Vyawahare, Parag J Ratnakar, Nageswari R Gandham, Poonam V Suryawanshi. Uncovering silent carriers: Hematological insights and viral burden in incidentally detected hepatitis B virus infection. World Journal of Hepatology 2026; 18(1): 113247 doi: 10.4254/wjh.v18.i1.113247
|
| 4 |
Shulin Xia, Xiaomin He, Jianhe Gan, Jiachen Ding. Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. Infection and Drug Resistance 2025; : 5949 doi: 10.2147/IDR.S536426
|
